NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Fountain Therapeutics

Fountain Therapeutics

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.fountainml.com/

Last Round

Series B

Aug 13, 2025

Total Funding Raised

$44M

Company Overview

Fountain Therapeutics is a biotechnology company that develops targeted therapeutics to reverse cellular aging and treat age-related diseases using an artificial intelligence-driven drug discovery platform.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

phenotypic drug discoveryAI drug discoveryhigh-content imagingcellular agingcomputer visionage-related diseasebiotech AIdrug discovery platformin silico drug discoveryregenerative medicinemachine learningpre-clinical researchcomputational biologypharma partnership

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fountain Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Fountain Therapeutics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Fountain Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BAug 13, 2025
Series A ExtensionNov 18, 2021
Series A ExtensionMay 19, 2020
Series AMay 1, 2018

Fountain Therapeutics Investors

Notable investors and investment history

Fountain Therapeutics investors
InvestorRounds
Khosla VenturesSeries A Extension
Nan Fung Life SciencesSeries A Extension, Series A
EOS VenturesSeries B
Alexandria Venture InvestmentsSeries A Extension
R42 GroupSeries A Extension
Alexandria Venture InvestmentsSeries A Extension

Fountain Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Fountain Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Fountain Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range4
Year Founded2018
Last FundingAug 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.